We've upgraded AI Search on TaxTMI with two powerful modes:
1. Basic • Quick overview summary answering your query with references• Category-wise results to explore all relevant documents on TaxTMI
2. Advanced • Includes everything in Basic • Detailed report covering: - Overview Summary - Governing Provisions [Acts, Notifications, Circulars] - Relevant Case Laws - Tariff / Classification / HSN - Expert views from TaxTMI - Practical Guidance with immediate steps and dispute strategy
• Also highlights how each document is relevant to your query, helping you quickly understand key insights without reading the full text.Help Us Improve - by giving the rating with each AI Result:
Physician samples valuation dispute under Central Excise Act dismissed, pro-rata basis upheld. The appeal challenging the valuation of physician samples for excise duty under the Central Excise Act, 1944 and Central Excise Valuation Rules, 2000 was ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Physician samples valuation dispute under Central Excise Act dismissed, pro-rata basis upheld.
The appeal challenging the valuation of physician samples for excise duty under the Central Excise Act, 1944 and Central Excise Valuation Rules, 2000 was dismissed. The Tribunal upheld the valuation based on precedents from Cadila Pharmaceuticals Ltd. and Medley Pharmaceuticals Ltd., determining that physician samples should be valued on a pro-rata basis. The appellant's argument for a different valuation method was rejected, leading to the dismissal of the appeal.
Issues: Valuation of physician samples for excise duty under Central Excise Act, 1944 and Central Excise Valuation Rules, 2000.
Issue 1: Valuation of physician samples under Central Excise Act, 1944 and Central Excise Valuation Rules, 2000
The case involved a manufacturer of P or P Medicines appealing against the order upholding the valuation of physician samples for excise duty under section 4A of the Central Excise Act, 1944. The appellant contended that physician samples, not meant for sale and not required to be affixed with MRP, should not be valued under section 4A. The department issued a show cause notice demanding excise duty based on the difference in valuation. The Assistant Commissioner upheld the demand under Rule 4 of Central Excise Valuation Rules 2000. The Commissioner (Appeals) also affirmed the decision, citing that even if samples are for marketing, once MRP is mentioned, valuation should be as per MRP under section 4A. The appellant's argument that valuation should be under Rule 11 read with Rule 8 of Central Excise Valuation Rules 2000 was rejected. The Tribunal referred to the decisions in Cadila Pharmaceuticals Ltd. and Medley Pharmaceuticals Ltd., where it was held that physician samples should be valued on a pro-rata basis. The appellant's method of valuation adding 15% profit was not accepted, leading to the dismissal of the appeal.
Conclusion: The appeal challenging the valuation of physician samples for excise duty under the Central Excise Act, 1944 and Central Excise Valuation Rules, 2000 was dismissed based on the precedents and legal interpretations provided by the Tribunal and the Supreme Court.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.